MedTrace Logo

The Efficacy of Acetium Lozenges in Intervention for Smoking Cessation

NCT02758743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1998

Last updated 2017-06-23

No results posted yet for this study

Summary

The purpose of this study is to validate the novel hypothesis that regular use of Acetium Lozenge is promising novel method to assist in smoking cessation.

The aim of this confirmatory study is to affirm the promising results obtained in a previous smoking intervention trial with Acetium lozenge. If successful, the trial gives adequate power to confirm, that the Acetium lozenge represents a breakthrough in the development of smoking intervention methods.

Conditions

  • Smoking Cessation

Interventions

DRUG

Acetium Lozenge

Slow-release L-Cysteine to block smoke.derived acetaldehyde in saliva thereby inhibiting the formation of harmans

DRUG

Placebo

Placebo with no active substance will not have the effect on intervention device.

Sponsors & Collaborators

  • Biohit Oyj

    lead INDUSTRY

Principal Investigators

  • Kari Syrjänen, MD, PhD · Biohit Oyj

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758743 on ClinicalTrials.gov